Perrigo Company plc (NYSE:PRGO) Shares Sold by Aster Capital Management DIFC Ltd

Aster Capital Management DIFC Ltd decreased its position in shares of Perrigo Company plc (NYSE:PRGO) by 91.3% in the fourth quarter, HoldingsChannel reports. The firm owned 1,168 shares of the company’s stock after selling 12,228 shares during the quarter. Aster Capital Management DIFC Ltd’s holdings in Perrigo were worth $30,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently bought and sold shares of the company. Franklin Resources Inc. acquired a new position in Perrigo in the third quarter valued at approximately $3,717,000. Barclays PLC lifted its holdings in Perrigo by 44.8% in the third quarter. Barclays PLC now owns 120,502 shares of the company’s stock valued at $3,160,000 after acquiring an additional 37,268 shares during the period. JPMorgan Chase & Co. lifted its holdings in Perrigo by 65.1% in the third quarter. JPMorgan Chase & Co. now owns 541,000 shares of the company’s stock valued at $14,190,000 after acquiring an additional 213,221 shares during the period. Virtu Financial LLC acquired a new position in Perrigo in the third quarter valued at approximately $909,000. Finally, Access Investment Management LLC acquired a new position in Perrigo in the fourth quarter valued at approximately $7,989,000. 95.91% of the stock is owned by institutional investors and hedge funds.

Perrigo Stock Up 5.1 %

Perrigo stock opened at $25.81 on Thursday. The company has a debt-to-equity ratio of 0.94, a current ratio of 2.56 and a quick ratio of 1.77. Perrigo Company plc has a 12 month low of $23.14 and a 12 month high of $33.46. The stock has a market capitalization of $3.52 billion, a PE ratio of -22.06 and a beta of 0.49. The business has a 50 day simple moving average of $26.46 and a 200-day simple moving average of $26.09.

Perrigo (NYSE:PRGO) last issued its quarterly earnings results on Thursday, February 27th. The company reported $0.93 EPS for the quarter, topping the consensus estimate of $0.92 by $0.01. Perrigo had a positive return on equity of 7.38% and a negative net margin of 3.64%. The firm had revenue of $1.14 billion during the quarter, compared to analysts’ expectations of $1.20 billion. On average, analysts anticipate that Perrigo Company plc will post 2.56 EPS for the current fiscal year.

Perrigo Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 25th. Investors of record on Friday, March 7th were given a dividend of $0.29 per share. This represents a $1.16 annualized dividend and a dividend yield of 4.50%. This is a boost from Perrigo’s previous quarterly dividend of $0.28. The ex-dividend date was Friday, March 7th. Perrigo’s payout ratio is presently -92.80%.

Insider Buying and Selling

In other Perrigo news, EVP Ronald Craig Janish sold 7,800 shares of the firm’s stock in a transaction on Monday, March 10th. The stock was sold at an average price of $27.44, for a total value of $214,032.00. Following the completion of the sale, the executive vice president now directly owns 33,666 shares of the company’s stock, valued at $923,795.04. This trade represents a 18.81 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.40% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of research analysts have issued reports on the company. Piper Sandler downgraded Perrigo from an “overweight” rating to a “neutral” rating and decreased their price target for the company from $34.00 to $27.00 in a report on Monday, January 6th. Argus cut Perrigo from a “buy” rating to a “hold” rating in a research report on Tuesday, January 14th. Finally, StockNews.com cut Perrigo from a “buy” rating to a “hold” rating in a research report on Wednesday, February 19th. Four investment analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $33.00.

About Perrigo

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.